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The study investigates conformational analysis and the in vitro cytokine-mediated 
immunomodulatory and insulin-releasing activities of rhinophrynin-27 
(ELRLPEIARPVPEVLPARLPLPALPRN; RP-27), a proline-arginine-rich peptide first 
isolated from skin secretions of the Mexican burrowing toad Rhinophrynus dorsalis 
(Rhinophrynidae). In both water and 50% trifluoroethanol-water, the peptide adopts a 
polyproline type II helical conformation with a hig degree of deviation from the canonical 
collagen-like folding and a pronounced bend in the molecule at the Glu13 residue.  Incubation 
of mouse peritoneal cells with RP-27 significantly (P < 0.05) inhibited production of the pro-
inflammatory cytokines TNF-α and IL-1β and stimulated production of the anti-inflammatory 
cytokine IL-10. The peptide significantly (P < 0.01) stimulated release of insulin from BRIN-
BD11 rat clonal β-cells at concentrations ≥ 1 nM while maintaining the integrity of the 
plasma membrane and also stimulated insulin release from isolated mouse islets at a 
concentration of 10-6 M. Increasing the cationicity of RP-27 by substituting glutamic acid 
residues in the peptide by arginine and increasing hydrophobicity by substituting alanine 
residues by tryptophan did not result in analogues with increased activity with respect to 
cytokine production and insulin release. The combinatio  of immunosuppressive and 
insulinotropic activities together with very low cytotoxicity suggests that RP-27 may 
represent a template for the development of an agent for use in anti-inflammatory and Type 2 
diabetes therapies. 
 







GLP-1:   Glucagon-like peptide-1   
GRAVY: Grand Average of Hydropathy  
IL-1β:     Interleukin-1β 
IL-10:     Interleukin-10 
KRB:      Krebs-Ringer bicarbonate buffer 
LDH:      Lactate dehydrogenase 
RMSD:   Root mean square deviation  
RP-27:    Rhinophrynin-27 
RP-33:    Rhinophrynin-33 
T2DM:   Type 2 diabetes mellitus 
TFE:      Trifluoroethanol 
TNF-α:  Tumor necrosis factor-alpha 
















1.  Introduction 
 
The Mexican burrowing toad Rhinophrynus dorsalis is the sole extant representative 
of the Rhinophrynidae, a phylogenetically ancient family of frogs that is the sister-group to 
the more extensive Pipidae family [1]. Peptidomic analysis of norepinephrine-stimulated 
secretions from R. dorsalis led to the isolation of a proline-arginine-rich peptide, termed 
rhinophryinin-27 (RP-27) together with a C-terminally extended form termed rhinophrynin-
33 (RP-33) [2]. RP-27 shows limited structural similarity to the porcine multifunctional 
peptide PR-39 [3] but, unlike this peptide, it displayed no growth-inhibitory activity against 
the Gram-positive Staphylococcus epidermidis and Gram-negative Escherichia coli bacteria 
and against the opportunistic yeast pathogen Candida parapsilosis (MIC > 128 µM) and 
lacked cytotoxic activity against mouse erythrocytes (LC50 > 500 µM) and A549 human non-
small cell lung adenocarcinoma  cells (LC50 > 100 µM) [2]. Circular dichroism studies 
suggested that RP-27 adopts a polyproline type II (PPII) helical structure in aqueous solution 
and a conformation composed of a PP-II helix and turn structures in the presence of sodium 
dodecyl sulphate micelles [2]. 
 Many peptides that were first identified in frog skin secretions as a result of their 
antimicrobial activities and abilities to lyse mammalian cells have subsequently been shown 
to be multifunctional. Biological activities not directly linked to cytotoxicity include 
cytokine-mediated immunomodulatory properties [4], stimulation of insulin release from 
clonal β-cells and isolated pancreatic islets [5] and glucagon-like peptide-1 release from 
enteroendocrine cells [6] together with β-cell proliferative and anti-apoptotic [7], wound 
healing [8] and anti-oxidative [9] activities. The aim of the present study was three-fold: (1) 
to determine the conformation of the peptide in aqueous solution and membrane-mimetic 
media using 1H-NMR spectroscopy, (2) to investigate its biological activities in order to 
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assess the potential for development into an agent with therapeutic relevance, and (3) to gain 
insight into the possible physiological role of theRP-27 in its species of origin. To these 
ends, the effects of incubation with synthetic RP-27, RP-33 and selected analogues with 
increased cationicity and increased hydrophobicity on the production of pro- and anti-
inflammatory cytokines by mouse peritoneal cells and release of insulin from BRIN-BD11 rat 
clonal β-cells [10] were investigated. 
 
2.    Materials and methods 
 
2.1.   Peptides 
 
RP-27, RP-33 and all analogues were supplied in crude form by Synpeptide Co., Ltd 
(Shanghai, China). The peptides were purified by reversed-phase HPLC on a (2.2 cm x 25 
cm) Vydac 218TP1022 (C-18) column equilibrated with acetonitrile/ water/trifluoroacetic 
acid (28.0/71.9.9/0.1, v/v/v) at a flow rate of 6 mL/ in. The concentration of acetonitrile was 
raised to 56 % (v/v) over 60 min using a linear gradient. Absorbance was measured at 214 nm 
and the major peak in the chromatogram was collected manually. The identities of the 
peptides were confirmed by electrospray mass spectromet y and their final purities were > 
98%. The primary structures, calculated isoelectric points (pI) [11], and Grand Average of 
Hydropathy (GRAVY) calculated from the Wimley-White amino acid hydrophobicity scales 







Table 1. Primary structure and physicochemical properties of the rhinophrynin 
peptides used in this study 
 
                                                  pI     GRAVY                                                                                                                 
 
RP-27                  ELRLPEIARPVPEVLPARLPLPALPRN         10.72   -0.36 
RP-33                  ELRLPEIARPVPEVLPARLPLPALPRNKMAKNQ   11.36     -0.39    
[E1R]RP-27             RLRLPEIARPVPEVLPARLPLPALPRN         11.66   -0.32  
[E1R,E6R]RP-27           RLRLPRIARPVPEVLPARLPLPALPRN         12.14   -0.28   
[E1R,E6R,E13R]RP-27    RLRLPRIARPVPRVLPARLPLPALPRN           13.28   -0.24    
[A8W]RP-27             ELRLPEIWRPVPEVLPARLPLPALPRN         10.72   -0.29  
[A8W,A17W]RP-27        ELRLPEIWRPVPEVLPWRLPLPALPRN         10.72   -0.22   
[A8W,A17W,A23W]RP-27   ELRLPEIWRPVPEVLPWRLPLPWLPRN         10.72   -0.14   
              
 
pI represents the calculated isoelectric point and GRAVY represents the Grand Average of 
Hydropathy. 
 
2.2.   Nuclear magnetic resonance 
 
Peptides were dissolved in 700 µL of either H2O/D2O (9/1 v/v) or 
H2O/trifluoroethanol-d3 (TFE-d3; 1/1 v/v) at a final concentration of 2.5 mM. The m thyl 
resonance of TSP-d4 (~1 mM) was used as internal reference both for 
1H and 13C chemical 
shift scale. NMR spectra were recorded at 300oK with a Unity Inova 500NM high-resolution 
spectrometer (Agilent Technologies, CA, USA) operating at a 1H frequency of 500 MHz, 
equipped with an indirect detection probe. 1H spectra were acquired using a 6.1 µs pulse 
(90°), 3 s delay time, 1.5 s acquisition time and a spectral width of 8 kHz. The WET 
sequence [13,14] was applied to suppress the water signal (100 Hz wide uburp shape centered 
at water resonance). 2D experiments, namely, 1H-1H gradient correlation spectroscopy 
(gCOSY), 1H-1H double-quantum filtered COSY (dqfCOSY), 1H-1H total correlation 
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spectroscopy (TOCSY) and 1H-1H nuclear Overhauser effect spectroscopy (NOESY) were 
acquired over the same spectral window, sampling each of the 512 increments (256 for 
gCOSY) with 2048 complex points and 48 scans. Mixing t me was 80 and 200 ms for the 
TOCSY and NOESY, respectively. The 1H-13C gradient heteronuclear single-quantum 
correlation (gHSQC) spectra were acquired using a spectral width of 8 kHz and 21 kHz for 
1H and 13C, respectively. 
 
2.3.   NMR-based structure calculation 
 
     3D structures of peptides were obtained by combining the simulated annealing algorithm 
implemented in the NMR molecular dynamics and analysis system DYNAMO [15] and 
experimentally derived restraints. Scalar coupling constants between 1HN and 
1Hα within the 
same residue were measured and related to the Φ backbone torsion angle through the Karplus 
equation [16]. Only J-coupling values lower than 6 Hz or larger than 8 Hz were considered, 
in order to avoid overinterpretation of values lying i  the dynamic average range. NOESY 
cross-peaks (NOEs) were classified on the basis of their relative intensity as strong, medium 
and weak, and upper limits of 0.27, 0.33 and 0.50 nm were applied, respectively, to restrain 
the corresponding inter-proton distances. Only unambiguously assigned NOEs were 
considered. A harmonic potential was applied to the pot ntial energy above the upper limit, 
while contribution was zero otherwise. 
 A statistical analysis was performed on the 1Hα, 1Hβ, 13Cα and 13Cβ chemical shift 
values with the software TALOS+ [17]. Briefly, TALOS+ takes the peptide sequence as input 
and analyses it in terms of successive (i-1, i, i+1) residue triplets. For each of these, the ten 
best-matched triplets are searched in a high-resolution structure database by comparing both 
the experimental chemical shift values provided and the residue types. In parallel, the 
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prediction output of the implemented artificial neural network is also compared. The final 
prediction of Φ/Ψ backbone torsion angles is very stringent. The prediction is ranked as valid 
(“good”) only if the central residue of all the 10 best-matched triplets are found in the same 
region of the Ramachandran plot, otherwise it is designated as ambiguous (“warn”). In 
addition, if a random coil index (RCI) order parameter S2 is predicted to be less than 0.5, the 
residue is categorized as “dynamic” and no value for either Φ and Ψ is considered during 
structure calculations [18,19]. In the present work, nly the “good” predictions were used as 
torsional angles restraints. 
 1000 structures were calculated with 5k steps at 4000oK and 20k steps of cooling 
down to zero. Solvent molecules were not included in the calculations. The 100 conformers 
with the lowest potential energy were selected for the analysis. Among the latter, the 
conformer with the minimum average root mean square deviation (RMSD) from all the 
others was selected as representative (cluster centroid). Then, all successive RMSD 
calculations were performed by using this representative structure as reference. In order to 
calculate the backbone bending angle at the site of r sidue E13, we calculated the minimum 
angle between two vectors, whose tail and head point were obtained as the centre of gravity 
of the backbone atoms of selected residues as follows: 13, 12 and 11 (vector 1 tail); 10 and 9 
(vector 1 head); 13, 14 and 15 (vector 2 tail); 16 and 17 (vector 2 head). 
 
2.4.   Effects on cytokine production 
 
Experiments were performed on cells collected from the peritoneal cavities of 
unstimulated 8-week-old C57BL/6 mice under sterile conditions using 5 mL of cold 
phosphate-buffered saline as previously described [20]. Isolated cells, comprising a mixed 
population of immune cells with predominance of macrophages and B cells, were suspended 
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in Dulbecco's Modified Eagle Medium culture medium containing 10% fetal bovine serum. 
Peptides (5 and 20 µg mL-1) were incubated with cells (2 x 105 cells/well) for 24 h at 37°C in 
three independent incubations with 5- 6 mice per group.  After incubation, cell-free 
supernatants were collected and kept at -20°C untiltime of analysis. Concentrations of tumor 
necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β) and interleukin-10 (IL-10) were 
determined in triplicate using ELISA Duosets from R & D Systems (Minneapolis, MN, USA) 
according to manufacturer’s recommended protocols. 
 
2.5.    Insulin release studies using BRIN-BD11 cells 
 
BRIN-BD11 rat clonal β-cells were seeded into 24-well plates and allowed to attach 
during overnight incubation at 37 °C. Incubations with purified synthetic peptides (10-12 - 3 
x10−6  M, n = 8) were carried out for 20 min at 37°C in Krebs-Ringer bicarbonate (KRB) 
buffer supplemented with 5.6 mM glucose as previously described [21].  After incubation, 
aliquots of cell supernatant were removed for insuli  radioimmunoassay [22]. Control 
incubations were carried out in parallel with the wll-established insulin stimulatory agents 
10 mM alanine and 10 nM human glucagon-like peptide-1 (GLP-1).  In order to investigate 
the effects of the peptides on the integrity of the plasma membrane, peptides (10-7 - 3 x 10-6  
M; n = 4)  were incubated with BRIN-BD11 cells for 20 min 37°C  and  the rate of lactate 
dehydrogenase (LDH) release was measured using a CytoTox 96 non-radioactive cytotoxicity 
assay kit (Promega, Southampton, UK) according to the manufacturer’s instructions as 






2.6.    Insulin release studies using mouse islets 
 
The preparation of isolated pancreatic islets from adult, male National Institutes of 
Health NIH Swiss mice (Harlan Ltd, Bicester, UK) and the procedure for determining the 
effects of peptides on the rate of insulin release has been described previously [24].  The 
islets were incubated for 1 h at 37°C with RP-27 in KRB buffer supplemented with 16.7 mM 
glucose. Control incubation with GLP-1 (10-8 and 10-6 M), 10 mM alanine, and KRB buffer 
containing 16.7 mM glucose alone were carried out in parallel. Supernatants were removed 
for determination of insulin concentration by radioimmunoassay. The islet cells were 
retrieved and extracted with acid-ethanol to determine total insulin content as previously 
described [23]. 
 
2.7.  Statistical analysis 
 
The distributions of data were evaluated for normality using Kolmogorov-Smirnov 
test and then retested with Chi-Square test. Comparison of quantitative parametric data 
between two study groups was done by application of unpaired t-test. Differences between 
the paired data were evaluated using paired t-test or Mann-Whitney test as appropriate. A P-











3.1. NMR-based structure calculation.  
 
Resonance assignments of RP-27 in H2O/D2O (9:1 v/v) and H2O/TFE-d3 (1:1 v/v) are 
reported in Tables S1 and S2, respectively. Fig. S1 shows the two corresponding 1H-NMR 
spectra. Significant difference in the resonance positions can clearly be seen. This is 
particularly evident for the HN resonances between 7.5 and 9.0 ppm, which are also spread 
over a larger frequency range in the presence of 50% v/v TFE (0.56 and 0.85 ppm in 0% and 
50% TFE, respectively), indicating that the level of structuration increased with TFE 
addition. The statistical analysis performed with TALOS+ on the measured chemical shifts of 
both 1H and 13C indicated no well-defined secondary structure even in the presence of TFE. 
Nevertheless, while residues from positions 2 to 6 and from 17 to 26 were predicted to be part 
of the peptide’s flexible regions in water, in the pr sence of TFE the backbone angles were 
predicted to be more restricted for the entire sequence. While the number of residues in the 
PP-II region is the same in water and in 50%. TFE-water, in the latter solvent we found an 
increased number of residues in the right-handed portion of the Ramachandran plot. On the 
basis of TALOS+ results, backbone torsion angles were r strained for only 40% of the amino 
acid residues in water, while the restraints were included for up to 80% of the residues in the 
presence of TFE. As far as the dipolar contacts are concerned, only sequential NOEs were 
identified in both the solvents. In particular, strong 1H-1H dipolar interactions were observed 
only between the Hα of the ith-residue and the HN of the ith+1-residue. In water, a total of 
only 12 inter-proton distance restraints were included in the structure calculations, while up 
to 20 inter-proton distances were restrained in the presence of TFE. Almost all the 3JHN-Hα 
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coupling constants were found in the 6-8 Hz range (Tables S1 and S2) which is typically 
observed for unstructured or very flexible peptides [24].  
The Ramachandran plots obtained from the analysis of the 100 structures with the 
minimum potential energy out of the one thousand calcul ted through DYNAMO are shown 
in Fig.1. Both torsions and inter-nuclear distances w re restrained during the calculations on 
the basis of the NMR results. Both the distribution and the standard deviation bars obtained in 
aqueous solution were larger than in the presence of 50%. TFE-water, clearly showing a more 
defined peptide conformation. In water, all the proline residues (Fig.1A, red data points) 
appeared to be almost identical, sharply populating the PP-II region of the Ramachandran 
plot except for residue P5 which is located at the beginning of the peptide sequence. As 
expected, proline residues showed more restricted plasticity compared with the other amino 
acids as can be seen by the smaller standard deviation bars in both the Φ and Ψ dimensions. 
On the other hand, the leucine residues (Fig.1A, blue data points) show very large standard 
deviation bars in the Φ dimension. This suggests that there is a significant probability of 
finding the leucine residues in the left-handed helical region of the plot which is quite 
unusual for residues other than glycine. It is worth noting that all the leucine residues are 
located on the N-terminal side of one proline residue. The only exception is L2, whose large 
standard deviation bars is explained by its localization at the very beginning of the peptide 
sequence. In addition, only two other residues withΦ error bars exceeding the center of the 
plot were found, namely, R9 and R26. While the latter is located at the very end of the 
peptide sequence, R9 is located on the N-terminal sde of one proline. Finally, we found 6 
non-leucine and non-proline residues in the PP-II region of the Ramachandran plot, which in 
addition to the 6 out of 7 prolines makes a total of 12 residues with backbone angles typical 






Fig. 1. Ramachandran plot of RP-27 in (A) H2O:D2O 9:1 v/v and  (B) H2O/TFE d3 1:1 v/v. 
The most energy-favored regions are reported according to Lovell et al. [25]. 
 
In 50% TFE-water, the amino acid residues appeared to be well segregated into two 
distinct regions of the plot, namely the PP-II and  region corresponding to a not well-
defined, right-handed helical conformation with about 3 residues per turn. Major differences 
from the results obtained in water are: (A) only 2 proline residues are found in the PP-II 
region, and (B) almost all leucine residues moved to the PP-II region. Residues populating 
the helical region are grouped in short and separated portions along the peptide sequence, 
namely, residues 2-3, 5-7, 12-13, 16 - 18, and 22-23. This implies that the peptide 
conformation is characterized by numerous and abrupt changes from right-handed to left-
handed coils proceeding from the N-terminus to the C-t rminus. While the number of 
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residues in the PP-II region is the same in water and in 50%. TFE-water, in the latter solvent 
we found an increased number of residues in the right-handed portion of the Ramachandran 
plot. 
The 3D view of the backbone trace of the 100 conformers obtained with the lowest 
potential energy in the two solvents is shown in Fig. 2. The RMSD was calculated by using 
the cluster centroid as reference. When the RMSD was calculated on the basis of the 
alignment performed over almost the entire peptide sequence (Figs. 3A and C), the lowest 
value was obtained in 50% TFE-water, indicating lower plasticity in this solvent. However, 
the difference was not dramatic, as shown by the standard deviations obtained, making the 
two proposed conformations quite comparable. In both cases, a clear bend was observed at 
the site of residue Glu13 separating two linear extended portions up to residues 9 and 18. 
Consequently, structure alignment was also performed ov r the region from Arg9 to Arg18 in 
order to visualize better the bend (Figs. 3B and D).  RMSD results confirmed the lower 
plasticity in 50%. TFE-water. The bending angle of the backbone was estimated to be 120 ± 








Fig. 2. Backbone trace (3D view) of the 100 conformers with the lowest potential energy 
obtained for RP-27 in H2O:D2O (9:1 v/v) (panels (A and B) and H2O:TFE d3 (1:11 v/v ) 
(panels C and D). Conformers were aligned on the basis of two different portions of the 
sequence, namely residues 4 to 24 (A and C) and residues 9 to 18 (B and D). The 
corresponding mean values of the backbone RMSD fromthe cluster centroid with the 
standard deviation in parentheses are reported. The red spheres in panels B and D represent 
the alpha carbon of residue E13. 
 
3.2.    Effects on cytokine production  
 
Incubation of mouse peritoneal cells with RP-27 at a concentration of 5 µg/mL 
(approx. 1.5 nM) significantly (P < 0.05) increased production of the anti-inflammatory 
cytokine IL-10 (Fig. 4A) and inhibited production of the pro-inflammatory cytokines TNF-α 
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(Fig. 4B) and IL-1β (Fig. 4C). RP-33 inhibited the production of TNF-α only (Fig. 4B). 
Increasing cationicity of the peptide by the substitution Glu1→ Arg abolished the effects of 
the peptide on TNF-α, IL-1β and IL-10 production at both 5 µg/mL and 20 µg/mL 
concentrations. Increasing cationicity further by the additional substitution Glu6→ Arg had 
no significant effect on TNF-α production but restored the ability of RP-27 to inhibit 
production of IL-1β and enhance production of IL-10 at the concentration of 20 µg/mL. The 
ability to stimulate significantly IL-10 production as well as inhibit IL-1β production was 
restored in the very strongly cationic tri-substituted analogue [E1R,E6R,E13R]RP-27 
(calculated pI 13.28) but the peptide was without effect on TNF-α production at 5 µg/mL and 
20 µg/mL concentrations. The tryptophan-containing a alogues of RP-27 ([A8W]RP-27 and 
[A8W,A17W]RP-27) did not show any significant effect on the production of TNF-α, IL-1β 
and IL-10 when tested in doses of 5 and 20 µg/mL. The strongly hydrophobic tri-substituted 
analogue [A8W,A17W,A23W]RP-27 significantly increased IL-10 production at the 
concentration of 20 µg/mL while inhibition of  TNF-α production was observed at the 






Fig. 3. Effects on the production of (A) IL-10, (B) TNF-α and (C) IL-1β  by peritoneal cells 
from unstimulated C57BL/6 mice by rhinophrynin-27 and it analogs (5 µg/mL and 10 





3.4.   Effects on insulin release by BRIN-BD11 cells 
 
In the presence of 5.6 mM glucose alone, the rate of r lease of insulin from BRIN-
BD11 clonal β-cells was 0.69 ± 0.02 ng/106 cells/20 min.  RP-27 produced a concentration-
dependent increase in the rate of insulin release (Fig. 4). The threshold concentrations 
(minimum concentrations of peptide producing a significant (P < 0.05) increase in insulin 
release compared with 5.6 mM glucose alone) was 1 nM. At the highest concentration tested 
(3 µM), the peptide produced an approximately 3-fold increase in the rate of insulin release. 
At concentrations up to and including 3 µM, incubation with RP-27 had no effect upon the 
rate of release of the cytosolic enzyme lactate dehy rogenase demonstrating that the integrity 
of the plasma membrane of the cells had been preserved. The effects of substitution of the 
glutamic acid residues in RP-27 by arginine and substitution of the alanine residues by 
tryptophan are summarized in Table 2. The substitution Glu1→ Arg in RP-27 resulted in a 
decrease in insulinotropic potency (threshold concentration 10 nM) and further substitutions 
by arginine in the [E1R,E6R] and [E1R,E6R,E13R] analogues resulted in loss of activity at 
concentrations up to and including 3 µM. RP-33 and ll tryptophan-containing peptides 










Glucose (5.6 mM) + Alanine (10 mM)
Glucose (5.6 mM) + GLP-1 (10-8 M)
Glucose (5.6 mM) +  Rhinophrynin-27




























Fig. 4.  Effects of increasing concentrations of rhinophryrin-27 on the release of insulin from 
BRIN-BD11 clonal β-cells. ** P < 0.01, ***P < 0.001 compared with release in the presence 















Table 2. Effects of rhinophrynin-27 and its analogues on the rate of insulin release from 
BRIN-BD11 clonal β-cells 
 
                 
Peptide Threshold  
Conc. (M) 
Max. effect  
 
 









>3 x 10-6 
 
100 ± 3  








>3 x 10-6 
 
102 ± 4 
 
[E1R,E6R,E13R]RP-27     
 
>3 x 10-6 
 
100 ± 4 
 
[A8W]RP-27              
 
>3 x 10-6 
 
101 ± 7 
 
[A8W,A17W]RP-27        
 
>3 x 10-6 
 
107 ± 2 
 
[A8W,A17W,A23W]RP-27   
 
>3 x 10-6 
 
108 ± 3 
 
 
Threshold concentration refers to the minimum concentration of peptide producing a 
significant increase in the rate of insulin release compared with the rate in the presence of 
glucose only. Max. effect refers to % increase in the rate of insulin release in the presence of 
3 µM peptide compared with the rate in the presence of 5.6 mM glucose alone (100%). NA: 








3.5.   Effect on insulin release by mouse pancreatic islets 
 
The  rate of insulin release from mouse islets in the presence of 16.7 mM glucose 
control was 7.7 ± 1.2 % of the total insulin content of the islets released in 60 min. RP-27 at 
1µM concentration produced a significant (P < 0.01) increase in the rate of insulin release 
compared with the rate with glucose only (Fig. 5) The effect of 1 µM RP-27  (12.9 ± 0.7% of 
total insulin released in 60 min) was significantly less than that produced by 1 µM GLP-1 



















16.7mM glucose  + GLP-1
10-8























Fig. 5.  Effects of rhinophryrin-27 on the release of insulin from isolated mouse islets.  






4.  Discussion 
 
Skin secretions from the Mexican burrowing toad R. dorsalis, in common with frogs 
from the genus Pipa but unlike those from Xenopus, Hymenochirus, and Pseudhymenochirus 
(Pipidae), do not contain cationic, α-helical host-defense peptides with antimicrobial 
properties [2]. This observation led to suggestion hat the ability to produce such peptides by 
frogs within the Pipidae family arose in the common ancestor of (Hymenochirus + 
Pseudhymenochirus) + Xenopus after divergence from the line of evolution leading to extant 
Pipa species [2].  However, R. dorsalis secretions do contain the non-cytotoxic peptide RP-
27 whose biological activities and functional role ar  completely unknown. Orthologous 
peptides have not been found in skin secretion of members of the Pipidae family studied to-
date [9,26]. 
Both in water and in the presence of 50% TFE-water, RP-27 adopts an extended 
conformation with a marked bend at the site of E13. The distribution of the backbone Φ/Ψ 
angles on the Ramachandran plot (Fig. 1) supports the previous interpretation of the circular 
dichroism spectra [2]. In water, the strong negative band at 200 nm was taken as indicative of 
a type II polyproline (PP-II) helical structure, and the absence of the characteristic positive, 
although small, band expected at 220 nm was attribued to deviation from the ideal PP-II 
conformation. The PP-II structure was also suggested on the basis of a small shift of the 
negative band from the wavelength typical for unordere  structures (195 nm) and supported 
by the large number of proline residues in the RP-27 sequence. In the present work, in 
addition to the proline residues, we found around 50% of the residues in the PP-II region of 
the Ramachandran plot (Fig. 1A), with the majority of the other amino acids localized in left-
handed coil regions. These results confirm that, in water, RP-27 adopts a general PP-II-like 
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conformation with a high degree of deviation from the canonical collagen-like folding and 
high plasticity. 
In 50% TFE-water, we found a similar situation with the same number of residues 
located in the PP-II region of the Ramachandran plot, a though the number of proline 
residues in this region decreased (Fig. 1B). Plasticity was clearly reduced in this solvent and 
the amino acid residues were well separated in two groups, namely PP-II and right-handed 
coil (3 residues per turn). The increased proportion of residues in right-handed coils was 
probably responsible for the increased intensity of the negative band at about 225 nm in the 
circular dichroism spectrum [2]. An overall extended structure was obtained, very similar to 
the one obtained in water, with a marked bend at the site of residue E13. The angle of this 
bend was smaller in the presence of TFE but the diff rence with the structure obtained in 
water was rather small, when the standard deviation is taken into consideration. Our study 
indicates that the overall structure of RP-27 in soluti n is only slightly influenced by the 
presence of TFE, which acts to stabilize a particular conformation that was already well 
established in water. When RP-27 sequence is compared to the canonical PP-II helix in 
collagen, the amino-acid pattern is quite different. The collagen primary structure is 
characterized by -G-x-y- repetitive triplets, where x and y are often P residues. In the case of 
RP-27, two consecutive proline residues are not found and the peptide exhibits 
the   -P-x-P-y-x-x-P-x-y-x-P-x-P- motif in the middle of the sequence (residues 10 to 22), 
where x and y are hydrophobic and hydrophilic residues, respectively. A particular feature of 
the proposed structure of RP-27 is the almost 90° bend in the middle of the sequence. An 
unexpected observation arising from the study was th t a BLAST search revealed that RP-27 
shows appreciable sequence identity to a region of a sub-unit of the trimeric MtrE outer 
membrane channel of bacterium Neisseria gonorrhoeae (Fig. S3) [27]. This small portion of 
24 
 
the 447 amino acid residue protein also exhibits an approximately 90° bend. The significance, 
if any, of these observations is unknown. 
R. dorsalis is rarely seen in the wild, emerging from its underground burrow only to 
reproduce after the first rains [28], so that it is not readily amenable to physiological 
investigations. However, the observed immunomodulatory properties of RP-27 in mice may 
be relevant to the biological significance of the peptide in its species of origin. Both innate 
and adaptive immune responses are involved in the abilities of frogs to defend against 
infections by pathogenic microorganisms in the environment. It has been shown that 
macrophage activation in the skin of Xenopus tropicalis is a major response to infection by 
Mycobacterium liflandii leading to granulomatous inflammation [29]. The prsent study has 
shown that RP-27 inhibits the production of the pro-inflammatory cytokines TNF-α and IL-
1β by mouse peritoneal cells and stimulates production of the anti-inflammatory cytokine IL-
10 thereby creating a predominately immunosuppressiv  environment, This may serve to 
modulate an excessive and potentially harmful inflammatory response triggered by exposure 
to pathogens. A previous study has shown that the frog skin peptides tigerinin-1M, -1R and -
1V, while lacking antimicrobial and hemolytic activi es, significantly enhance the production 
of IL-10 by mouse peritoneal macrophages and human peripheral blood mononuclear cells 
[30]. However, immunosuppression is not a universal ch racteristic of frog skin-derived 
peptides. For example, frenatin-2D from Discoglossus sardus (Alytidae) [31] and plasticin-
L1 from Leptodactylus laticeps (Leptodactylidae) [32], which like RP-27 lack antimicrobial 
and cytotoxic activities, stimulate production of TNF-α and IL-1β by mouse peritoneal cells.   
The immunomodulatory properties of RP-27 may have clinical relevance in terms 
drug development. Endotoxemic complications of infection, such as severe sepsis and septic 
shock are a major cause of death particularly in intensive care units [33]. The importance of 
agents that modulate the immune function of the host in the treatment of sepsis is well 
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recognized [34] and several immunoregulatory peptides have shown therapeutic potential in 
attenuating the inflammatory response triggered by bacteria [35].  In view of its ability to 
inhibit production of TNF-α and IL-1β and stimulate IL-10 production by peritoneal cells, it 
will be worthwhile to investigate the ability of RP-27 to attenuate the early 
hyperinflammatory response that follows bacterial infection in an appropriate animal model.    
Such a study in a model of acute inflammation may provide additional insight into the 
relevance of RP-27 and analogues in experimental therapy.   
Defective insulin release is a characteristic of patients with long-standing Type 2 
diabetes mellitus (T2DM). Several frog skin-derived peptides show therapeutic potential for 
treatment of such patients by virtue of their insulinotropic activities (reviewed in [5]). These 
compounds generally, but not invariably, have the ability to adopt an amphipathic α-helical 
conformation in a membrane-mimetic solvent or in the presence of a phospholipid micelle. 
This study has shown that RP-27, which adopts a polypr line type II helical conformation in 
solution, also stimulates insulin release from rat clonal β-cells (Fig. 3) and mouse pancreatic 
islets (Fig. 4) at concentrations that do not increase the rate of LDH release. However, the 
potency and maximum response produced by the peptide were significantly less than the 
corresponding parameters for GLP-1.  Metabolic syndrome is associated with insulin 
resistance, impaired glucose tolerance, high blood pressure and elevated circulating 
concentrations of cholesterol and triglycerides [36].  Elevated levels of TNF-α induce insulin 
resistance in adipocytes and peripheral tissues by impairing insulin signalling [37]. Another 
critical event in the pathogenesis of T2DM is IL-1β mediated autoinflammation followed by 
β-cell death [38]. Neutralization of IL-1β or blockade of its receptor has showed beneficial 
effects on the restoring of β-cell function and even regeneration of islets [39]. Consequently, 
blocking TNF-α and IL-1β production by RP-27 in conjunction with its ability to stimulate 
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IL-10 production and insulin release may represent part of an effective strategy for 
preventing the progression of metabolic syndrome into T2DM.  
Attempts to increase the insulinotropic potency and/or effectiveness of RP-27 or its 
ability to modulate cytokine production by synthesis of selected analogs were disappointing. 
Increasing cationicity by progressive substitutions f glutamic acid residues by arginine and 
increasing hydrophobicity by progressive substitutions of alanine residues by tryptophan 
resulted in peptides that showed either decreased activity or were inactive (Table 2). The 
mechanism of action of RP-27 is unknown at this time and it seems highly improbable that 
cells from laboratory rodents would contain a specific receptor for a frog peptide with very 
restricted distribution. The speculation arises that RP-27 is binding to a receptor whose 
natural ligand is mammalian peptide that adopts a stable polyproline type II helical 
conformation.  This structural feature occurs frequently in proteins and is believed to have an 
important functional role in protein-protein or protein-nucleic acid interactions and 
recognition [40]. The observation that modification f the C-terminus of the peptide by 
addition of the cationic hexapeptide sequence KMAKNQ in the naturally occurring RP-33 
abolishes insulin-releasing activity and the ability to inhibit production of IL-1β and IL-10 
suggests that the C-terminal domain of RP-27 may be particularly important in interacting 
with any putative receptor. As RP-33 is present in R. dorsalis skin secretions in appreciably 
higher concentration than RP-27 [2], the data suggest th  RP-33 is a biosynthetic precursor of 
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Research Highlights 
 
• In water and 50% TFE-water, RP-27 adopts a polyproline type II helical 
conformation. 
• The conformation contains a marked bend at the site of E13. 
• RP-27 inhibited production of TNF-α and IL-1β and stimulated production of IL-
10. 
• RP-27stimulated release of insulin from BRIN-BD11 clonal β-cells at 
concentrations ≥ 1 nM. 
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